Georg Widhalm

Research interests

Publications

• Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

  Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-01935-8

• Longitudinal molecular trajectories of diffuse glioma in adults

  Nature · 2019 · https://doi.org/10.1038/s41586-019-1775-1

• The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

  Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0156-x

• Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases

  European Radiology · 2017 · https://doi.org/10.1007/s00330-016-4707-6

• Correlation of immune phenotype with IDH mutation in diffuse glioma

  Neuro-Oncology · 2017 · https://doi.org/10.1093/neuonc/nox054

• Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

  Journal of Neuro-Oncology · 2016 · https://doi.org/10.1007/s11060-016-2216-8

• Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

  ESMO Open · 2016 · https://doi.org/10.1136/esmoopen-2015-000024

• Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

  OncoImmunology · 2015 · https://doi.org/10.1080/2162402x.2015.1057388

• What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

  Neurosurgery · 2015 · https://doi.org/10.1227/neu.0000000000000929

• Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

  Neuro-Oncology · 2014 · https://doi.org/10.1093/neuonc/nou307

Current projects

No projects listed.